Allergy Immunotherapy Market: Novel Developments in SCIT to Witness a Proliferated Adoption Rate and Remain a Massive Growth Propeller: Global Industry Analysis (2015-2016) and Opportunity Assessment (2017-2025)

  • Published: 2019-03-11
  • Report Code: REP-GB-9043

An Incisive, In-depth Analysis on the Allergy Immunotherapy Market

This study offers a comprehensive, 360 degree analysis on the Allergy Immunotherapy market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Allergy Immunotherapy market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

There is a sheer rise in the pervasiveness of allergies and conventional treatment interventions, such as pharmacotherapy, has been often found inadequate. As a result, allergy immunotherapy, also known as hypo-sensitization or desensitization, is gaining popularity for curing several types of allergies by increasing immunological tolerance and changing the course of the disease. Immunotherapy offers a long-term cure, which even lasts post the treatment of allergies, thereby, enhancing the quality of life for allergic patients.

The global allergy immunotherapy market is growing at an impressive pace, which can be attributed to the increasing consciousness of patients pertaining to the allergy treatment, rising number of allergic patients, and development of novel products. According to a recently published report by Future Market Insights (FMI), the global allergy immunotherapy market is anticipated to clock a notable CAGR of over 10% through 2025. The allergy immunotherapy market is expected to achieve a valuation of US$ 3.33 Bn by 2025 end.

Launch of Innovative Products in the Allergy Immunotherapy Market to Remain a Robust Growth Driver

Conventionally, allergy tablets gained popularity after the US Food and Drug Administration (FDA) permitted the utilization of Sublingual immunotherapy (SLIT) tablets to cure ragweed as well as grass pollen allergies. Such tablets are used to reduce the symptoms of allergy by increasing the tolerance of the allergen effects. However, the allergy tablets are capable to cure only a specific type of allergen and remains incompetent to prevent the development of new allergies, asthma and new products are in demand in the allergy immunotherapy market.

As a result, subcutaneous immunotherapy (SCIT) has been gaining traction in the allergy immunotherapy market, on account of its competency to modify the immune system and control the growth of allergies. In the year 2016, SCIT accounted for over 65% of the share in the global allergy immunotherapy market and is anticipated to contribute massively through the forecast period.

Rising Awareness of Allergies among the Patients is expected to be a Prominent Revenue Enabler to the Allergy Immunotherapy Market

As stated by the World Allergy Organization, a notable rise in the pervasiveness of allergies has been witnessed in the recent past. About 30% of the total world population have allergic rhinitis. As per Summary Health Statistics for the U.S. Adults, more than 8% of the adults in the U.S. suffer from sinusitis and hay fever. As a subsequence to the awareness created by these health organizations, governments of numerous countries have sanctioned budget for the research and development of allergy immunotherapy as an effective cure. This is one of the robust factors, which is expected to reflect substantially on the size of the allergy immunotherapy market.

Europe to Remain a Lucrative Region for the Expansion of the Allergy Immunotherapy Market

As compared to the allergy immunotherapy market of North America, Asia Pacific, the Middle East and Africa, and Latin America, Europe is anticipated to hold the largest market share through the forecast period. This is attributed to the rising awareness of allergies, surging budgets for R&D, convenient medical reimbursement policies, growing number of allergic patients, and efficient clinical pipeline products, which are fueling the growth of the allergy immunotherapy market.

On the contrary, the Asian Pacific allergy immunotherapy market is expected to grow at a steady rate, on account of a large number of the allergic population present in China and Japan.

Proliferated Adoption of Novel SLIT Therapies by the Manufacturers to Intensify the Growth Rate of Allergy Immunotherapy Market

The report highlights some of the leading players in the global allergy immunotherapy market include WOLW Pharma, Holister Stier, Leti, Allergopharma, Stallergenes Greer, Allergy Therapeutics, ALK-Abello A/S, HAL Allergy Group, Biomay AG, Circassia, DBV Technologies, Aimmune Therapeutics, and Merck KGaA, among others. The study on allergy immunotherapy market incorporates business strategies of the competitors to assist the stakeholders of the allergy immunotherapy market. With a view to sustaining the competition, the manufacturers of the global allergy immunotherapy market are rapidly adopting novel SLIT therapies to meet the unfulfilled demand of the consumers.

Allergy Immunotherapy Market - Introduction

A new report published by Future Market Insights (FMI) lends a holistic view of the global allergy immunotherapy market. This study provides an incisive look by analysing the restraints, opportunities, drivers, and pipeline products that could impact the growth of the allergy immunotherapy market. Market size has been analysed in the report in terms of revenue (US$ Mn). The allergy immunotherapy market has been studied by considering 2016 as the base year and the period 2017 to 2025 is the forecast period. This provides historical year-on-year growth data of the global allergy immunotherapy market.

The report analyses the existing as well as the future growth prospects of the allergy immunotherapy market. This will help the key stakeholders such as the manufacturers and distributors as well as the new entrants of the allergy immunotherapy market in devising sustainable strategies. The report commences with an executive summary to provide brief information about the market and its segmentation. Key trends and the recent development of the allergy immunotherapy market have been incorporated in this report, in order to help the stakeholders of the market.

Allergy Immunotherapy Market - Segmentation

This exclusive study assesses market attractiveness with the help of market segmentation. The allergy immunotherapy market has been bifurcated on the basis of region, distribution channel, treatment type and allergy type. Depending on the treatment type, allergy immunotherapy market has been segmented into sublingual immunotherapy & subcutaneous immunotherapy.

On the basis of the allergy type, the allergy immunotherapy market can be classified into asthma, allergic rhinitis, venom allergy, and food allergy, among others. Based on the distribution channel, the global allergy immunotherapy market has been fragmented into online pharmacies, retail pharmacies and drug stores, and hospital pharmacies.

Allergy Immunotherapy Market – Regional Analysis

Depending on the regions, the global allergy immunotherapy market can be classified into North America, the Middle East and Africa, Europe, Latin America, and Asia Pacific. The size and prediction for each of these regions have been incorporated in this report, along with their CAGRs for the forecasted period.

Significant countries in these regions that contribute to the growing size of the allergy immunotherapy market have also been assessed in this report. Qualitative analysis of the market has been carried out to provide information on the drivers, restraints, and opportunities prevailing in the global allergy immunotherapy market. The study also comprises of detailed analysis of market attractiveness for these regions.

Allergy Immunotherapy Market – Competition Analysis

Significant players operating in the allergy immunotherapy market comprise of Anergis, Biomay AG, Circassia, DBV Technologies, HAL Allergy Group, Merck KGaA, Allergy Therapeutics, ALK-Abello A/S, Aimmune Therapeutics, Stallergenes Greer, WOLW Pharma, Holister Stier, Allergopharma, and Leti, among others. The report encapsulates competitive scenario in order to help the stakeholders of the market understand the competition prevailing in the allergy immunotherapy market.

This market study includes a detailed overview of the companies, which provides valuable insights into the HQ, employee strength, and business segments. A detailed analysis of the product portfolio has been incorporated in this market study that provides details about the latest development in the allergy immunotherapy market.

The comprehensive study comprises of comprehensive SWOT analysis, which provides information on the key opportunities and challenges that could impact the growth of the global allergy immunotherapy market. In addition to this, the report incorporates strategic overview for each of the aforementioned firms, which helps understand the business strategies adopted by the market players. Financial overview of the significant companies of the allergy immunotherapy market has been included in this study, which will help the new entrants of the market understand the size and valuation of the companies.

Allergy Immunotherapy Market Reports - Table of Contents

Allergy Immunotherapy Market Reports - List of Tables

Table 01: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025

Table 02: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025

Table 03: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025

Table 04: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Region, 2015–2025

Table 05: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025

Table 06: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel , 2015–2025

Table 07: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025

Table 08: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025

Table 09: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025

Table 10: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025

Table 11: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025

Table 12: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025

Table 13: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025

Table 14: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025

Table 15: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025

Table 16: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025

Table 17: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Types, 2015–2025

Table 18: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025

Table 19: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025

Table 20: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025

Table 21: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025

Table 22: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025

Table 23: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025

Table 24: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025

Allergy Immunotherapy Market Reports - List of Figures

Figure 01: Market Snapshot 

Figure 02: Market Value Share By Treatment Type (2017) Value (US$ Mn)

Figure 03: Market Value Share By Allergy Type (2017) Value (US$ Mn)

Figure 04: Market Value Share By Distribution Channel (2017) Value (US$ Mn)

Figure 05: Global Allergy Immunotherapy Market Value Share Analysis, by Type, 2016 and 2025

Figure 06: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by SCIT, 2015–2025

Figure 07: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by SLIT, 2015–2025

Figure 08: Global Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025

Figure 09: Global Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025

Figure 10: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2015–2025

Figure 11: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2015–2025

Figure 12: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies and Drug Store, 2015–2025

Figure 13: Global Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025

Figure 14: Global Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025

Figure 15: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Allergic Rhinitis, 2015–2025

Figure 16: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Asthma, 2015–2025

Figure 17: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Food Allergy, 2015–2025

Figure 18: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Venom Allergy, 2015–2025

Figure 19: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2027

Figure 20: Global Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type , 2017–2025

Figure 21: Global Allergy Immunotherapy Market Value Share Analysis, by Region, 2016 and 2025

Figure 22: Global Allergy Immunotherapy Market Attractiveness Analysis, by Region, 2017–2025

Figure 23: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025

Figure 24: North America Allergy Immunotherapy Y-o-Y Growth (%) Projection, 2016–2025

Figure 25: North America Allergy Immunotherapy Market Attractiveness, by Country, 2017–2025

Figure 26: North America Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025

Figure 27: North America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025

Figure 28: North America Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025

Figure 29: North America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025

Figure 30: North America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025

Figure 31: North America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025

Figure 32: North America Allergy Immunotherapy Market Value Share Analysis, by Country, 2016 and 2025

Figure 33: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025

Figure 34: Europe Allergy Immunotherapy Market Y-o-Y Growth Projections, 2016–2025

Figure 35: Europe Allergy Immunotherapy Market Attractiveness, by Country, 2016

Figure 36: Europe Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025

Figure 37: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025

Figure 38: Europe Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025

Figure 39: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025

Figure 40: Europe Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025

Figure 41: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025

Figure 42: Europe Allergy Immunotherapy Market, by Country, 2016 and 2025

Figure 43: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025

Figure 44: Asia Pacific Allergy Immunotherapy Market Y-o-Y Growth Projections, 2016–2025

Figure 45: Asia Pacific Allergy Immunotherapy Market Attractiveness, by Country, 2016

Figure 46: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025

Figure 47: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025

Figure 48: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025

Figure 49: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025

Figure 50: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025

Figure 51: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025

Figure 52: Asia Pacific Surgical Drapes Market, by Country, 2016 and 2025

Figure 53: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025

Figure 54: Latin America Allergy Immunotherapy Y-o-Y Growth Projections, 2016–2025

Figure 55: Latin America Allergy Immunotherapy Market Attractiveness, by Country, 2016

Figure 56: Latin America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025

Figure 57: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025

Figure 58: Latin America Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025

Figure 59: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025

Figure 60: Latin America Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025

Figure 61: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025

Figure 62: Latin America Allergy Immunotherapy Market, by Country, 2016 and 2025

Figure 63: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025

Figure 64: Middle East & Africa Allergy Immunotherapy Y-o-Y Growth (%) Projection, 2016–2025

Figure 65: Middle East & Africa Allergy Immunotherapy Market Attractiveness, by Country, 2017-2025

Figure 66: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025

Figure 67: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025

Figure 68: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025

Figure 69: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025

Figure 70: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025

Figure 71: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025

Figure 72: Middle East & Africa Allergy Immunotherapy Market, by Country, 2016 and 2025

Figure 73: Global Allergy Therapeutics Market Share Analysis, by Company (2017)

Figure 74: ALK-Abello A/S Global Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 75: ALK-Abello A/S Global Operating Profit (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 76: ALK-Abello A/S Breakdown of Net Sales, by Region, 2017

Figure 77: ALK-Abello A/S Breakdown of Net Sales, by Business Segment, 2017

Figure 78: Allergy Therapeutics Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 79: Allergy Therapeutics Breakdown of Net Sales, by Region, 2017

Figure 80: Allergy Therapeutics Breakdown of Net Sales, by Business Segment, 2017

Figure 81: Stallergenes Greer Breakdown of Net Sales, by Business Segment, 2017

Figure 82: Stallergenes Greer R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 83: Stallergenes Greer Breakdown of Net Sales, by Region, 2017

Figure 84: Stallergenes Greer Breakdown of Net Sales, by Business Segment, 2017

Figure 85: Merck KGaA Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 86: Merck KGaA R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 87: Merck KGaA Breakdown of Net Sales, by Region, 2017

Figure 88: Merck KGaA Breakdown of Net Sales, by Business Segment, 2017

Figure 89: Circassia Global Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016

Figure 90: Circassia Global Research and Development Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology